New Age Alpha Advisors’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.93M Sell
78,450
-2,735
-3% -$190K 0.23% 121
2025
Q4
$5.39M Sell
81,185
-28,543
-26% -$1.85M 0.23% 113
2025
Q3
$7.38M Sell
109,728
-2,524
-2% -$200K 0.31% 71
2025
Q2
$9.8M Sell
112,252
-13,238
-11% -$1.04M 0.43% 39
2025
Q1
$8.57M Sell
125,490
-63,557
-34% -$5.19M 0.38% 56
2024
Q4
$14.7M Buy
+189,047
New +$14M 0.59% 25

Other funds holding DXCM

New Age Alpha Advisors's DXCM Position: Q1 2026 in Review

New Age Alpha Advisors reduced its DexCom (DXCM) stake by 3.4% in Q1 2026, selling an estimated $190K and leaving 78,450 shares worth $4.93M. The position accounts for 0.23% of the portfolio, ranked #121.

New Age Alpha Advisors first reported a position in DXCM in Q4 2024 and has held it in 6 quarters since. The position peaked at $14.7M in Q4 2024. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • New Age Alpha Advisors held 78,450 shares of DexCom worth $4.93M as of Q1 2026.
  • New Age Alpha Advisors sold 2,735 DexCom shares in Q1 2026, an estimated $190K.
  • DexCom made up 0.23% of New Age Alpha Advisors's portfolio in Q1 2026, its #121 holding.
  • New Age Alpha Advisors first reported a position in DexCom in Q4 2024 and has held it in 6 quarters since.
  • New Age Alpha Advisors's DexCom position peaked at $14.7M in Q4 2024.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on New Age Alpha Advisors's 13F filing for Q1 2026, filed 11 May 2026.